Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, Viking Therapeutics (VKTX) has a market cap of $2.59 billion USD. According to our data, Viking Therapeutics is ranked No.3570 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $2.59 B |
-42.20%
|
| Dec 31, 2024 | $4.49 B |
116.23%
|
| Dec 29, 2023 | $2.08 B |
97.98%
|
| Dec 30, 2022 | $1.05 B |
104.35%
|
| Dec 31, 2021 | $0.51 B |
-18.29%
|
| Dec 31, 2020 | $0.63 B |
-29.80%
|
| Dec 31, 2019 | $0.89 B |
4.84%
|
| Dec 31, 2018 | $0.85 B |
88.42%
|
| Dec 29, 2017 | $0.45 B |
241.18%
|
| Dec 30, 2016 | $0.13 B |
-65.10%
|
| Dec 31, 2015 | $0.38 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
USA
|
 Amgen
AMGN
|
$158.77 B |
0.132 B
|
USA
|
 Biogen
BIIB
|
$17.12 B |
0.000 M
|
USA
|
 Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
USA
|
 Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
USA
|
 Ionis Pharmaceuticals
IONS
|
$4.51 B |
0.000 M
|
USA
|
 Moderna
MRNA
|
$10.14 B |
-0.001 M
|
USA
|
 Pfizer
PFE
|
$127.27 B |
-0.003 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
USA
|
 Vertex Pharmaceuticals
VRTX
|
$128.67 B |
-0.003 M
|
USA
|
 Novartis
NVS
|
$217.12 B |
0.003 M
|
Switzerland
|
 Merck
MRK
|
$197.26 B |
0.003 M
|
USA
|
 Sanofi
SNY
|
$123.58 B |
-0.002 M
|
France
|
 Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
USA
|
| Market Cap | = | VKTX Stock Price | * | VKTX Shares Outstanding |
| = | $23.11 | * | 0.11 B | |
| = | $2.59 B |